1. Home
  2. EML vs TLSI Comparison

EML vs TLSI Comparison

Compare EML & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastern Company (The)

EML

Eastern Company (The)

HOLD

Current Price

$24.91

Market Cap

152.9M

ML Signal

HOLD

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

HOLD

Current Price

$4.87

Market Cap

270.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EML
TLSI
Founded
1858
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
152.9M
270.2M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
EML
TLSI
Price
$24.91
$4.87
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
9.6K
95.6K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
1.98%
N/A
EPS Growth
185.40
N/A
EPS
1.04
N/A
Revenue
$248,970,345.00
$45,151,000.00
Revenue This Year
$19.05
$35.45
Revenue Next Year
N/A
$37.58
P/E Ratio
$23.95
N/A
Revenue Growth
N/A
53.41
52 Week Low
$17.61
$2.20
52 Week High
$29.91
$7.95

Technical Indicators

Market Signals
Indicator
EML
TLSI
Relative Strength Index (RSI) 42.81 48.60
Support Level $24.10 $4.70
Resistance Level $27.16 $5.58
Average True Range (ATR) 1.36 0.28
MACD -0.25 -0.02
Stochastic Oscillator 16.23 43.33

Price Performance

Historical Comparison
EML
TLSI

About EML Eastern Company (The)

The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to the industrial market. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It has one reportable segment: Engineered Solutions, which provides engineered solutions mainly for the commercial transportation and logistics markets. This segment offers a diverse product line of custom and standard vehicular and industrial hardware, including turnkey returnable packaging solutions, blow molds, compression latches, draw latches, hinges, camlocksaccess, mirrors, and mirror-cameras, among other products. Geographically, the group derives maximum revenue from the United States.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

Share on Social Networks: